BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18042935)

  • 61. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
    Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
    Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
    [No Abstract]   [Full Text] [Related]  

  • 62. Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findings.
    Anderson GL; Barrington WE
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613938
    [No Abstract]   [Full Text] [Related]  

  • 63. A tangled web: factors likely to affect the efficacy of screening mammography.
    Baines CJ; Dayan R
    J Natl Cancer Inst; 1999 May; 91(10):833-8. PubMed ID: 10340902
    [No Abstract]   [Full Text] [Related]  

  • 64. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specifity and sensitivity of mamographic screening.
    Howard JM
    Eur J Gynaecol Oncol; 2006; 27(1):104; author reply 104. PubMed ID: 16550985
    [No Abstract]   [Full Text] [Related]  

  • 65. [Breast cancer, mammography screening and hormone therapy].
    Nielsen M
    Ugeskr Laeger; 2004 Aug; 166(34):2915. PubMed ID: 15449536
    [No Abstract]   [Full Text] [Related]  

  • 66. [Breast cancer, mammography screening and hormone therapy].
    Ersbøll J
    Ugeskr Laeger; 2004 Aug; 166(36):3113-4. PubMed ID: 15387316
    [No Abstract]   [Full Text] [Related]  

  • 67. Are breast cancer screening programmes increasing rates of mastectomy? Observational study.
    Paci E; Duffy SW; Giorgi D; Zappa M; Crocetti E; Vezzosi V; Bianchi S; Cataliotti L; del Turco MR
    BMJ; 2002 Aug; 325(7361):418. PubMed ID: 12193357
    [No Abstract]   [Full Text] [Related]  

  • 68. Prediction of hormone responsiveness by mammographic parenchymal pattern in advanced primary breast cancer.
    Nielsen NS; Andersen J; Poulsen HS; Mathiessen O
    Breast Cancer Res Treat; 1992; 23(3):219-22. PubMed ID: 1463861
    [TBL] [Abstract][Full Text] [Related]  

  • 69. National Centre for Screening Monitoring. Sixth report. Introduction.
    Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):5-6. PubMed ID: 18770991
    [No Abstract]   [Full Text] [Related]  

  • 70. Phleboliths detected on mammography.
    de Lourdes Díaz M; Pina LJ; Alonso A; De Luis E
    Breast J; 2006; 12(5):467-9. PubMed ID: 16958967
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Screening for breast carcinoma.
    Griesbach WA
    Oncology; 1969; 23(2):167-71. PubMed ID: 5787938
    [No Abstract]   [Full Text] [Related]  

  • 72. A rationale for starting breast cancer screening under age 50.
    van Schoor G; Broeders MJ; Paap E; Otten JD; den Heeten GJ; Verbeek AL
    Ann Oncol; 2008 Jun; 19(6):1208-9. PubMed ID: 18448450
    [No Abstract]   [Full Text] [Related]  

  • 73. Pattern of surgical disorders of the breast in Zambia.
    Desai G; Nalumango D; Manamnthu M
    Trop Doct; 1994 Oct; 24(4):187-8. PubMed ID: 7801378
    [No Abstract]   [Full Text] [Related]  

  • 74. Periodic mammography survey for occult carcinoma detection.
    Stevens GM
    Oncology; 1969; 23(2):172-3. PubMed ID: 5787939
    [No Abstract]   [Full Text] [Related]  

  • 75. [Overdiagnosis or wrong statement method?].
    Njor SH; Olsen AH; Lynge E
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2800; author reply 2800-1. PubMed ID: 15534684
    [No Abstract]   [Full Text] [Related]  

  • 76. Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
    Schouten LJ; de Rijke JM; Schlangen JT; Verbeek AL
    Lancet; 1997 Apr; 349(9058):1104. PubMed ID: 9107274
    [No Abstract]   [Full Text] [Related]  

  • 77. How do personal characteristics affect sensitivity and specificity of mammography?
    Kerlikowske K
    Nat Clin Pract Oncol; 2005 Jan; 2(1):16-7. PubMed ID: 16264848
    [No Abstract]   [Full Text] [Related]  

  • 78. The decline in breast cancer incidence: real or imaginary?
    Kurian AW; Clarke CA; Carlson RW
    Curr Oncol Rep; 2009 Jan; 11(1):21-8. PubMed ID: 19080738
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of hormone replacement therapy after mastectomy.
    Del Mar CB; Glasziou PP; Spinks AB; Sanders SL; Hilton DJ
    Med J Aust; 2002 Mar; 176(6):285. PubMed ID: 11999265
    [No Abstract]   [Full Text] [Related]  

  • 80. Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
    Banks E; Beral V; Reeves G;
    Climacteric; 2004 Dec; 7(4):415-6; author reply 416-7. PubMed ID: 15799614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.